Nephros (NEPH) Set to Post Earnings on Thursday

Nephros (NASDAQ:NEPH) is expected to announce its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of $0.02 per share and revenue of $5.49 million for the quarter. Parties may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

Nephros (NASDAQ:NEPH) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter. Nephros had a return on equity of 10.60% and a net margin of 8.38%. The business had revenue of $6.02 million for the quarter, compared to analyst estimates of $4.99 million. On average, analysts expect Nephros to post $0.15 EPS for the current fiscal year and $0.31 EPS for the next fiscal year.

Nephros Stock Performance

Shares of NASDAQ:NEPH opened at $3.24 on Wednesday. Nephros has a 1 year low of $2.66 and a 1 year high of $6.42. The stock has a market capitalization of $35.22 million, a P/E ratio of 20.25 and a beta of 1.76. The stock has a 50-day simple moving average of $3.86 and a 200-day simple moving average of $3.67.

Analysts Set New Price Targets

NEPH has been the topic of a number of recent research reports. Zacks Research raised shares of Nephros to a “hold” rating in a research report on Monday, July 20th. Benchmark reissued a “speculative buy” rating on shares of Nephros in a research report on Tuesday, August 18th. Weiss Ratings reissued a “hold (c)” rating on shares of Nephros in a research report on Friday. Finally, Northland Securities assumed coverage on shares of Nephros in a research note on Friday, July 17th. They issued a “market perform” rating and a $4.00 target price on the stock. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Nephros presently has an average rating of “Hold” and an average price target of $4.00.

About Nephros

Nephros, Inc is a medical device company that develops and sells filtration products designed to improve water quality and reduce the risk of waterborne contamination. Its technologies are based primarily on ultrafiltration membranes that remove bacteria, viruses, endotoxins, cysts and other impurities from water.

The company serves the healthcare market with filtration systems for hemodialysis and infection-control applications. Its products are designed for use in hospitals, dialysis centers and other healthcare facilities where purified water is important for patient care and clinical operations.

Nephros also offers commercial water-filtration products for applications such as foodservice, hospitality, commercial buildings and healthcare facilities.